Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in early disease

Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR—The European Alliance of Associations for Rheumatology—recommends early intervention in arthritis, since conventional synthetic disease-modifying antirheumatic drugs (csDMARD) have been shown to slow disease progression in both rheumatoid and psoriatic arthritis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup